Guillain-Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009

Nizar Souayah, P. A. Michas-Martin, Abu Nasar, Nataliya Krivitskaya, Hussam A. Yacoub, Hafiz Khan, Adnan I. Qureshi

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

Using data from Vaccine Adverse Event Reporting System, we identified 69 reports of Guillain-Barré Syndrome (GBS) after Gardasil vaccination that occurred in the United States between 2006 and 2009. The onset of symptoms was within 6 weeks after vaccination in 70% of the patients in whom the date of vaccination was known. The estimated weekly reporting rate of post-Gardasil GBS within the first 6 weeks (6.6 per 10,000,000) was higher than that of the general population, and higher than post-Menactra and post-influenza vaccinations. Further prospective active surveillance for accurate ascertainment and identification of high-risk groups of GBS after Gardasil vaccination is warranted.

Original languageEnglish (US)
Pages (from-to)886-889
Number of pages4
JournalVaccine
Volume29
Issue number5
DOIs
StatePublished - Jan 29 2011

Keywords

  • Adverse effect
  • Gardasil
  • Guillain-Barré syndrome
  • Papillomavirus
  • Vaccination

Fingerprint Dive into the research topics of 'Guillain-Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009'. Together they form a unique fingerprint.

Cite this